Cybin Announces Scientific Management Transition Following A

- Michael Palfreyman Ph.D. and Brett Greene, who joined Cybin as part of the acquisition of Adelia Therapeutics, move into advisory roles -


- Alex Nivorozhkin Ph.D. continues as Chief Scientific... | June 5, 2023

Related Keywords

Netherlands , Ireland , United Kingdom , United States , Canada , American , Doug Drysdale , Brett Greene , Exchange Commission , Twitter , Health Canada , Linkedin , Cybin Inc , Instagram , Youtube , Adelia Therapeutics Inc , Drug Administration , Adelia Therapeutics , Chief Rd Officer , Chief Innovations Officer , Chief Scientific Officer , Chief Executive Officer , Clinical Milestones , Cybin Inc Stock Exchange , News , Information , Press Release , Michael , Alfreyman , End , Brett , Who , Oined , Cybin , Us , Art , F , The , Cquisition , Rdelia , Cove , Into , Advisory , Roles , Flex , Ivorozhkin , Ontinues , Hief Cybn Ca23256x1006 ,